ArticleNucleic acids research2026
High-throughput methods enabling random duplications, deletions, or nucleotide-constrained mutagenesis of entire DNA motifs.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Currently available random and untargeted DNA mutagenesis techniques are limited by both the number of consecutive nucleotides that can be mutated and by the type of accessible mutations. These methodologies also create multiple different mutated sites within each DNA sequence-of-interest, which significantly confounds any precise and high-throughput phenotype-to-genotype mapping. Here, we describe two unique and cell-independent DNA mutagenesis methods that enable either a single random and small-scale (1-30 nt) duplication, deletion, or insertion of an entire DNA motif (RADDIM), or nucleotide-constrained mutagenesis of random DNA regions spanning >8 consecutive nucleotides (NSM). By utilizing these mechanistically unique methods, we randomly duplicated and deleted cryptic regulatory DNA elements in two yeast promoters (pACT1 and pTEF1) to change their transcriptional expression. We randomly mutated the protein structure of an inactivated β-lactamase (TEM-1) to restore its enzymatic function by generating multiple, consecutive in-frame InDels. We also selectively mutated the AT-content and introduced TATA-box-like sequences and homopolymeric mutations, within random DNA regions. Collectively, RADDIM and NSM allow for an unprecedented level of bespoke DNA mutagenesis at random DNA locations, expanding the toolkit for genetic engineering, directed evolution, and the functional mapping of novel protein structures and cryptic regulatory DNA motifs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.